Pharmacotherapy of comorbid mood, anxiety, and substance use disorders

被引：28
|
作者：
Brady, KT [1 ]
Verduin, ML [1 ]
机构：
[1] Med Univ S Carolina, Inst Psychiat, Charleston, SC 29425 USA
来源：
SUBSTANCE USE & MISUSE | 2005年 / 40卷 / 13-14期
关键词：
substance use; mood disorders; anxiety disorders; depression; bipolar disorder; panic disorder; post-traumatic stress disorder; obsessive compulsive disorder; social phobia; alcohol; cocaine; marijuana; opiates;
D O I：
10.1080/10826080500294924
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
Mood and anxiety disorders commonly co-occur with substance use disorders. Exploration of the neurobiology of substance use disorders and mood and anxiety disorders have found that the neural circuitry in mood, anxiety, and substance use disorders is clearly overlapping. These discoveries have encouraged the exploration of a number of pharmacotherapeutic agents in the treatment of co-occurring mood, anxiety, and substance use disorders. In this article, recent data on the pharmacotherapeutic treatment of mood and anxiety disorders in individuals with substance use disorders are reviewed. Some of the barriers to the use of pharmacotherapy in individuals with substance use disorders are discussed.
引用
收藏
页码：2021 / 2041
页数：21
相关论文
共 50 条
  • [1] Substance use disorders comorbid with mood and anxiety disorders in the Australian general population
    Prior, Katrina
    Mills, Katherine
    Ross, Joanne
    Teesson, Maree
    [J]. DRUG AND ALCOHOL REVIEW, 2017, 36 (03) : 317 - 324
  • [2] Pharmacotherapy for anxiety and comorbid alcohol use disorders
    Ipser, Jonathan C.
    Wilson, Don
    Akindipe, Taiwo O.
    Sager, Carli
    Stein, Dan J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (01):
  • [3] Comorbid Substance Use and Anxiety Disorders in Adolescents
    Deborah Deas-Nesmith
    Kathleen T. Brady
    Sallie Campbell
    [J]. Journal of Psychopathology and Behavioral Assessment, 1998, 20 : 139 - 148
  • [4] Comorbid substance use and anxiety disorders in adolescents
    Deas-Nesmith, D
    Brady, KT
    Campbell, S
    [J]. JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT, 1998, 20 (02) : 139 - 148
  • [5] Management of comorbid anxiety and substance use disorders
    Myrick, H
    Brady, K
    [J]. PSYCHIATRIC ANNALS, 2001, 31 (04) : 265 - 271
  • [6] The spectrum of substance use in mood and anxiety disorders
    Sbrana, A
    Bizzarri, JV
    Rucci, P
    Gonnelli, C
    Doria, MR
    Spagnolli, S
    Ravani, L
    Raimondi, F
    Dell'Osso, LD
    Cassano, GB
    [J]. COMPREHENSIVE PSYCHIATRY, 2005, 46 (01) : 6 - 13
  • [7] Anxiety, Mood, and Substance Use Disorders in Parents of Children With Anxiety Disorders
    Hughes, Alicia A.
    Furr, Jami M.
    Sood, Erica D.
    Barmish, Andrea J.
    Kendall, Philip C.
    [J]. CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2009, 40 (03) : 405 - 419
  • [8] Anxiety, Mood, and Substance Use Disorders in Parents of Children With Anxiety Disorders
    Alicia A. Hughes
    Jami M. Furr
    Erica D. Sood
    Andrea J. Barmish
    Philip C. Kendall
    [J]. Child Psychiatry and Human Development, 2009, 40 : 405 - 419
  • [9] Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders
    Hill, Kevin P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (10): : 1070 - +
  • [10] The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders
    Beaulieu, Serge
    Saury, Sybille
    Sareen, Jitender
    Tremblay, Jacques
    Schuetz, Christian G.
    McIntyre, Roger S.
    Schaffer, Ayal
    [J]. ANNALS OF CLINICAL PSYCHIATRY, 2012, 24 (01) : 38 - 55
12345